Outcomes in Chronic Hemodynamically Significant Aortic Regurgitation and Limitations of Current Guidelines

Li Tan Yang, Hector I Michelena, Christopher G. Scott, Maurice E Sarano, Sorin V. Pislaru, Hartzell V Schaff, Patricia Pellikka

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: Few data exist on the contemporary profiles and outcomes of patients with significant aortic regurgitation (AR). Objectives: This study sought to assess the benefits of aortic valve repair or replacement (AVR) and the prognostic value of left ventricular (LV) dimensions in significant AR. Methods: From 2006 to 2017, consecutive patients with ≥moderate-severe chronic AR without prior heart surgery, myocardial infarction, or overt coronary artery disease were included. Results: Of 748 participants (58 ± 17 years of age; 82% men), 387 (52%) were medically treated, and 361 (48%) had AVR. Of 361 patients having AVR, 334 (93%) met guideline criteria: Class I indications in 284 (79%) patients, which included symptoms in 236, and Class II indications in 50 (14%). The remaining 27 (7%) opted for surgery without Class I or II indications. At a median follow-up of 4.9 years (interquartile range: 2.3 to 8.3 years), 125 (17%) patients had died. Age, comorbidities, baseline symptoms, and higher LV end-systolic dimension index (LVESDi) were associated with all-cause mortality (all p ≤ 0.01). Compared with patients having LVESDi <20 mm/m 2 , those with LVESDi 20 to 25 mm/m 2 (hazard ratio: 1.53; 95% confidence interval: 1.01 to 2.31) and ≥25 mm/m 2 (HR: 2.23; 95% confidence interval: 1.32 to 3.77) had increased risks of death. AVR was associated with better survival (p < 0.0001). Patients with Class I indications for surgery had inferior post-operative survival (p < 0.003). Conclusions: Class I indications for surgery, mainly symptoms, are the most common triggers for AVR. Class II indications were associated with better post-operative outcome and thus merit more attention. LVESDi was the only LV parameter independently associated with all-cause mortality and the ideal cutoff seems to be lower than previously recommended.

Original languageEnglish (US)
Pages (from-to)1741-1752
Number of pages12
JournalJournal of the American College of Cardiology
Volume73
Issue number14
DOIs
StatePublished - Apr 16 2019

Fingerprint

Aortic Valve Insufficiency
Guidelines
Confidence Intervals
Survival
Mortality
Aortic Valve
Thoracic Surgery
Comorbidity
Coronary Artery Disease
Myocardial Infarction

Keywords

  • aortic regurgitation
  • echocardiography
  • guideline
  • left ventricular dimension
  • prognosis
  • surgery

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Outcomes in Chronic Hemodynamically Significant Aortic Regurgitation and Limitations of Current Guidelines. / Yang, Li Tan; Michelena, Hector I; Scott, Christopher G.; Sarano, Maurice E; Pislaru, Sorin V.; Schaff, Hartzell V; Pellikka, Patricia.

In: Journal of the American College of Cardiology, Vol. 73, No. 14, 16.04.2019, p. 1741-1752.

Research output: Contribution to journalArticle

@article{abdcf66ececc4d738b77933411586afa,
title = "Outcomes in Chronic Hemodynamically Significant Aortic Regurgitation and Limitations of Current Guidelines",
abstract = "Background: Few data exist on the contemporary profiles and outcomes of patients with significant aortic regurgitation (AR). Objectives: This study sought to assess the benefits of aortic valve repair or replacement (AVR) and the prognostic value of left ventricular (LV) dimensions in significant AR. Methods: From 2006 to 2017, consecutive patients with ≥moderate-severe chronic AR without prior heart surgery, myocardial infarction, or overt coronary artery disease were included. Results: Of 748 participants (58 ± 17 years of age; 82{\%} men), 387 (52{\%}) were medically treated, and 361 (48{\%}) had AVR. Of 361 patients having AVR, 334 (93{\%}) met guideline criteria: Class I indications in 284 (79{\%}) patients, which included symptoms in 236, and Class II indications in 50 (14{\%}). The remaining 27 (7{\%}) opted for surgery without Class I or II indications. At a median follow-up of 4.9 years (interquartile range: 2.3 to 8.3 years), 125 (17{\%}) patients had died. Age, comorbidities, baseline symptoms, and higher LV end-systolic dimension index (LVESDi) were associated with all-cause mortality (all p ≤ 0.01). Compared with patients having LVESDi <20 mm/m 2 , those with LVESDi 20 to 25 mm/m 2 (hazard ratio: 1.53; 95{\%} confidence interval: 1.01 to 2.31) and ≥25 mm/m 2 (HR: 2.23; 95{\%} confidence interval: 1.32 to 3.77) had increased risks of death. AVR was associated with better survival (p < 0.0001). Patients with Class I indications for surgery had inferior post-operative survival (p < 0.003). Conclusions: Class I indications for surgery, mainly symptoms, are the most common triggers for AVR. Class II indications were associated with better post-operative outcome and thus merit more attention. LVESDi was the only LV parameter independently associated with all-cause mortality and the ideal cutoff seems to be lower than previously recommended.",
keywords = "aortic regurgitation, echocardiography, guideline, left ventricular dimension, prognosis, surgery",
author = "Yang, {Li Tan} and Michelena, {Hector I} and Scott, {Christopher G.} and Sarano, {Maurice E} and Pislaru, {Sorin V.} and Schaff, {Hartzell V} and Patricia Pellikka",
year = "2019",
month = "4",
day = "16",
doi = "10.1016/j.jacc.2019.01.024",
language = "English (US)",
volume = "73",
pages = "1741--1752",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "14",

}

TY - JOUR

T1 - Outcomes in Chronic Hemodynamically Significant Aortic Regurgitation and Limitations of Current Guidelines

AU - Yang, Li Tan

AU - Michelena, Hector I

AU - Scott, Christopher G.

AU - Sarano, Maurice E

AU - Pislaru, Sorin V.

AU - Schaff, Hartzell V

AU - Pellikka, Patricia

PY - 2019/4/16

Y1 - 2019/4/16

N2 - Background: Few data exist on the contemporary profiles and outcomes of patients with significant aortic regurgitation (AR). Objectives: This study sought to assess the benefits of aortic valve repair or replacement (AVR) and the prognostic value of left ventricular (LV) dimensions in significant AR. Methods: From 2006 to 2017, consecutive patients with ≥moderate-severe chronic AR without prior heart surgery, myocardial infarction, or overt coronary artery disease were included. Results: Of 748 participants (58 ± 17 years of age; 82% men), 387 (52%) were medically treated, and 361 (48%) had AVR. Of 361 patients having AVR, 334 (93%) met guideline criteria: Class I indications in 284 (79%) patients, which included symptoms in 236, and Class II indications in 50 (14%). The remaining 27 (7%) opted for surgery without Class I or II indications. At a median follow-up of 4.9 years (interquartile range: 2.3 to 8.3 years), 125 (17%) patients had died. Age, comorbidities, baseline symptoms, and higher LV end-systolic dimension index (LVESDi) were associated with all-cause mortality (all p ≤ 0.01). Compared with patients having LVESDi <20 mm/m 2 , those with LVESDi 20 to 25 mm/m 2 (hazard ratio: 1.53; 95% confidence interval: 1.01 to 2.31) and ≥25 mm/m 2 (HR: 2.23; 95% confidence interval: 1.32 to 3.77) had increased risks of death. AVR was associated with better survival (p < 0.0001). Patients with Class I indications for surgery had inferior post-operative survival (p < 0.003). Conclusions: Class I indications for surgery, mainly symptoms, are the most common triggers for AVR. Class II indications were associated with better post-operative outcome and thus merit more attention. LVESDi was the only LV parameter independently associated with all-cause mortality and the ideal cutoff seems to be lower than previously recommended.

AB - Background: Few data exist on the contemporary profiles and outcomes of patients with significant aortic regurgitation (AR). Objectives: This study sought to assess the benefits of aortic valve repair or replacement (AVR) and the prognostic value of left ventricular (LV) dimensions in significant AR. Methods: From 2006 to 2017, consecutive patients with ≥moderate-severe chronic AR without prior heart surgery, myocardial infarction, or overt coronary artery disease were included. Results: Of 748 participants (58 ± 17 years of age; 82% men), 387 (52%) were medically treated, and 361 (48%) had AVR. Of 361 patients having AVR, 334 (93%) met guideline criteria: Class I indications in 284 (79%) patients, which included symptoms in 236, and Class II indications in 50 (14%). The remaining 27 (7%) opted for surgery without Class I or II indications. At a median follow-up of 4.9 years (interquartile range: 2.3 to 8.3 years), 125 (17%) patients had died. Age, comorbidities, baseline symptoms, and higher LV end-systolic dimension index (LVESDi) were associated with all-cause mortality (all p ≤ 0.01). Compared with patients having LVESDi <20 mm/m 2 , those with LVESDi 20 to 25 mm/m 2 (hazard ratio: 1.53; 95% confidence interval: 1.01 to 2.31) and ≥25 mm/m 2 (HR: 2.23; 95% confidence interval: 1.32 to 3.77) had increased risks of death. AVR was associated with better survival (p < 0.0001). Patients with Class I indications for surgery had inferior post-operative survival (p < 0.003). Conclusions: Class I indications for surgery, mainly symptoms, are the most common triggers for AVR. Class II indications were associated with better post-operative outcome and thus merit more attention. LVESDi was the only LV parameter independently associated with all-cause mortality and the ideal cutoff seems to be lower than previously recommended.

KW - aortic regurgitation

KW - echocardiography

KW - guideline

KW - left ventricular dimension

KW - prognosis

KW - surgery

UR - http://www.scopus.com/inward/record.url?scp=85063635664&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063635664&partnerID=8YFLogxK

U2 - 10.1016/j.jacc.2019.01.024

DO - 10.1016/j.jacc.2019.01.024

M3 - Article

VL - 73

SP - 1741

EP - 1752

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 14

ER -